Suppr超能文献

用于卫生技术评估的多标准决策分析(MCDA):昆士兰卫生部门的经验

Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.

作者信息

Howard Sarah, Scott Ian A, Ju Hong, McQueen Liam, Scuffham Paul A

机构信息

Healthcare Evaluation and Assessment of Technology, Healthcare Improvement Unit, Clinical Excellence Division, Queensland Department of Health, Level 2, 15 Butterfield Street, Herston, Qld 4006, Australia. Email.

Department of Internal Medicine and Clinical Epidemiology, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Qld 4102, Australia. Email.

出版信息

Aust Health Rev. 2019 Oct;43(5):591-599. doi: 10.1071/AH18042.

Abstract

Objectives In determining whether new health technologies should be funded, health technology assessment (HTA) committees prefer explicit to implicit methods of analysis in enhancing transparency and consistency of decision making. The aim of this study was to develop and pilot a multicriteria decision analysis (MCDA) framework for the Queensland Department of Health HTA program committee, which weighted decision making criteria according to their perceived importance as determined by group consensus. Methods The criteria used in the MCDA framework were identified by reviewing the five unweighted criteria used in the existing process, consultation with committee members and literature review. Criteria were clearly defined and ordinal categories of lowest to highest preferred were assigned against which technology submissions would be rated. Criteria weights were determined through a discrete choice experiment (DCE) survey of committee members using validated software. Mean weighted technology scores were then used to guide deliberative discussions in determining final funding decisions. Results The MCDA framework created one additional criterion to the previous five. The criteria and their mean weights identified through the DCE survey were clinical benefit and safety (27.2%), quality of evidence (19.2%), implementation capacity (16.9%), innovation (15.4%), burden of disease and clinical need (13.3%) and societal and ethical values (8.0%). Criterion weights varied considerably between individual committee members, with one criterion having a difference of 36.9% between the highest and lowest preference weights. Following deliberative discussions, all but one of 10 submissions were awarded funding. The submission not supported received the third lowest score through the MCDA model. Conclusions This pilot application of an MCDA framework, as a complement to committee deliberation, conferred greater transparency and objectivity on HTA assessment of technologies. The framework converted an implicit, unweighted review process to one that is more explicit, flexible in weighting importance and pragmatic. What is known about the topic? HTA programs involve complex decision-making processes requiring the consideration of multiple criteria. Explicit methods of analysis that use weighted criteria according to their relative importance enhance transparency and consistency of decision making by HTA committees, and are preferred to implicit reviews using unweighted criteria. What does this paper add? This article describes the development and piloting of an MCDA framework that aims to improve transparency, objectivity and consistency of funding decisions of the Queensland HTA committee. Criteria were identified through a review of current processes, committee discussions and a literature review, and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) quality of evidence system. Criteria were weighted using a discrete choice experiment involving committee members. Using weighted criteria, mean technology scores were calculated and incorporated into deliberative discussions to determine funding decisions. What are the implications for practitioners? The MCDA framework described here converted a more implicit, unweighted process to one that was more pragmatic, explicit and flexible in scoring HTA submissions. This framework may be useful to other HTA programs and could be expanded to resource allocation decision making in many other healthcare settings.

摘要

目标 在确定新的卫生技术是否应获得资金支持时,卫生技术评估(HTA)委员会在提高决策的透明度和一致性方面,更倾向于采用明确的分析方法而非隐含的方法。本研究的目的是为昆士兰卫生部HTA项目委员会开发并试行一个多标准决策分析(MCDA)框架,该框架根据委员会成员共同认定的重要性对决策标准进行加权。方法 通过回顾现有流程中使用的五个未加权标准、与委员会成员进行磋商以及文献综述,确定了MCDA框架中使用的标准。对标准进行了明确界定,并划分了从最低偏好到最高偏好的有序类别,据此对技术申报进行评分。通过使用经过验证的软件对委员会成员进行离散选择实验(DCE)调查来确定标准权重。然后,使用平均加权技术得分来指导审议讨论,以确定最终的资金决策。结果 MCDA框架在之前的五个标准基础上新增了一个标准。通过DCE调查确定的标准及其平均权重分别为临床效益与安全性(27.2%)、证据质量(19.2%)、实施能力(16.9%)、创新性(15.4%)、疾病负担与临床需求(13.3%)以及社会和伦理价值(8.0%)。各个委员会成员之间的标准权重差异很大,其中一个标准的最高偏好权重与最低偏好权重相差36.9%。经过审议讨论,10份申报中有9份获得了资金支持。未获支持的申报在MCDA模型中得分第三低。结论 作为委员会审议的补充,MCDA框架的此次试行应用使HTA技术评估具有了更高的透明度和客观性。该框架将一个隐含的、未加权的审查过程转变为一个更明确、在权重重要性方面更灵活且务实的过程。关于该主题已知的信息有哪些?HTA项目涉及复杂的决策过程,需要考虑多个标准。根据相对重要性使用加权标准的明确分析方法可提高HTA委员会决策的透明度和一致性,比使用未加权标准的隐含审查更受青睐。本文补充了哪些内容?本文描述了一个MCDA框架的开发和试行情况,该框架旨在提高昆士兰HTA委员会资金决策的透明度、客观性和一致性。通过回顾当前流程、委员会讨论和文献综述以及推荐分级评估、制定与评价(GRADE)证据质量系统来确定标准。通过涉及委员会成员的离散选择实验对标准进行加权。使用加权标准计算平均技术得分,并将其纳入审议讨论以确定资金决策。对从业者有何影响?此处描述的MCDA框架将一个更隐含、未加权的过程转变为一个在对HTA申报进行评分时更务实、明确且灵活的过程。该框架可能对其他HTA项目有用,并且可以扩展到许多其他医疗环境中的资源分配决策。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验